<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (BD) is a <z:hpo ids='HP_0011010'>chronic</z:hpo> relapsing-remitting <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorder</z:e> of unknown origin, affecting multiple organs </plain></SENT>
<SENT sid="1" pm="."><plain>Neurological involvement is one of the most devastating manifestations of BD and may be fatal </plain></SENT>
<SENT sid="2" pm="."><plain>We report a 36-year-old woman with neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet who was treated with low-dose pulse <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (St </plain></SENT>
<SENT sid="3" pm="."><plain>Thomas' protocol) and <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi>, with almost complete clinical remission </plain></SENT>
</text></document>